|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Inflammation in Drug Discovery and Development | ||||||||||||||||
| April 29, 2002 | ||||||||||||||||
|
Strategic Research Institute, Hyatt Regency Hotel 06/24/2002 - 06/25/2002 ORGANIZED INTO FOUR SECTIONS: * Novel Anti-TNF Proteins * Advances in Small Molecule Anti-TNF Inhibitors * IL-1 Receptors & Receptor Antagonists * Additional Approaches for Novel Anti-Inflammatory Drugs HIGHLIGHTS INCLUDE: Cytokine Signaling - Bench to Bedside NATIONAL INSTITUTES OF HEALTH Kineret(R) IL-1 Receptor Antagonist - A New Era in Antirheumatic Therapy AMGEN ICE Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases VERTEX PHARMACEUTICALS p38 MAPK Inhibitors: Potent Anti-Inflammatory Agents MERCK RESEARCH LABORATORIES Jun N-Terminal Kinase (JNK) Inhibitors CELGENE FEATURING: TNF Blockers BAFF TACE Inhibitors IRAK p38 Inhibitors Enbrel Kineret JNK Inhibitors NFkB Pathway IL-2 Receptor Antibody IKK Inhibitors ICE Inhibitors IL-1 Receptor Blockers Cytokine Traps DISEASES COVERED: Rheumatoid Arthritis Autoimmune Disorders Crohn's Disease Inflammatory Bowel Disease Psoriasis Pulmonary Fibrosis |
||||||||||||||||
| Organized by: | Strategic Research Institute | |||||||||||||||
| Invited Speakers: | PRESENTATIONS BY: Abbott Laboratories Amgen Biogen Celgene Immunex Merck Research Labs National Institutes of Health Nereus Pharmaceuticals Pharmacia Corporation Pfizer Global R & D - Groton Labs Protein Design Labs Regeneron Pharmaceuticals Roche Bioscience Johnson & Johnson PRI Scios Inc. Temple University Vertex Pharmaceuticals Wyeth Research II |
|||||||||||||||
| Deadline for Abstracts: | na | |||||||||||||||
| Registration: | n/a | |||||||||||||||
| E-mail: | ckahan-radhuber@srinstitute.com | |||||||||||||||
| Posted by: | Cheryl Kahan-Radhuber | |||||||||||||||
| Host: | 12.3.58.3 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||